Testosterone replacement to prevent type 2 diabetes? Not just yet.

Sattar, Naveed; Boyle, James G; Al-Ozairi, Ebaa

Sattar, Naveed; Boyle, James G; Al-Ozairi, Ebaa.

Sattar N; Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK. Electronic address: naveed.sattar@glasgow.ac.uk.
Boyle JG; Glasgow Royal Infirmary, Glasgow UK.
Al-Ozairi E; Clinical Research Unit, Dasman Diabetes Institute, Kuwait City, Kuwait.

Lancet Diabetes Endocrinol ; 9(1): 5-6, 2021 01.

Article in English | MEDLINE | ID: covidwho-1160655

Subject(s)

Diabetes Mellitus, Type 2; Hypogonadism; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/prevention & control; Double-Blind Method; Hormone Replacement Therapy; Humans; Hypogonadism/drug therapy; Life Style; Male; Testosterone/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Hypogonadism Type of study: Randomized controlled trials Limits: Humans / Male Language: English Journal: Lancet Diabetes Endocrinol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google